<?xml-stylesheet type="text/xsl" href="https://www.vetsurgeon.org/utility/feedstylesheets/rss.xsl" media="screen"?><rss version="2.0" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:slash="http://purl.org/rss/1.0/modules/slash/" xmlns:wfw="http://wellformedweb.org/CommentAPI/"><channel><title>Invicta launches treatment for equine lameness</title><link>/b/veterinary-news/posts/72894</link><description> Invicta
Animal Health has launched SynVet-50, a licensed synthetic Sodium Hyaluronate (HA), for intra-articular treatment
of lameness caused by joint dysfunction associated with non-infectious
synovitis in horses. 
 The product is Invicta&amp;#39;s first</description><dc:language>en-US</dc:language><generator>Telligent Community 10</generator></channel></rss>